Chaubey Alka 4
4 · Bionano Genomics, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Bionano (BNGO) CMO Alka Chaubey Withholds 18 Shares for Taxes
What Happened
- Alka Chaubey, Chief Medical Officer of Bionano Genomics (BNGO), had 18 shares of common stock withheld by the company to satisfy tax withholding obligations related to RSUs that vested. The filing reports these 18 shares disposed at an effective price of $1.10 per share, totaling $20, on 2026-02-17.
Key Details
- Transaction date: 2026-02-17
- Price per share: $1.10; total value: $20
- Transaction code: F (tax withholding by issuer)
- Reason: Withholding in connection with RSU award that vested on Feb 15, 2026 (award originally granted Feb 15, 2023) — 18 shares were not issued and were retained to cover taxes (see footnote F1)
- Shares owned after the transaction: not disclosed in the provided filing excerpt
- Filing date: 2026-02-18 (filed the next day); no late-filing indication in the excerpt
Context
- This was a tax-withholding event tied to RSU vesting, not an open-market sale or purchase by the insider. Such withholding is routine and reflects payroll/tax compliance rather than a trading decision. The amount involved ($20) is immaterial to investment conclusions.
Insider Transaction Report
Form 4
Chaubey Alka
CHIEF MEDICAL OFFICER
Transactions
- Tax Payment
Common Stock
[F1]2026-02-17$1.10/sh−18$20→ 644 total
Footnotes (1)
- [F1]The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact|2026-02-18